- Home
- Publications
- Publication Search
- Publication Details
Title
Wnt signaling and Loxl2 promote aggressive osteosarcoma
Authors
Keywords
-
Journal
CELL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-20
DOI
10.1038/s41422-020-0370-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway
- (2018) Xingwen Wang et al. CELL BIOLOGY INTERNATIONAL
- Recurrent rearrangements of FOS and FOSB define osteoblastoma
- (2018) Matthew W. Fittall et al. Nature Communications
- EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling
- (2018) Markus Linder et al. EMBO Molecular Medicine
- Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival
- (2017) Cecilia Folio et al. Cancer Biomarkers
- Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations
- (2016) M. Bousquet et al. ANNALS OF ONCOLOGY
- Histopathologic Features of Prognostic Significance in High-Grade Osteosarcoma
- (2016) Michael Herman Chui et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis
- (2016) D H Peng et al. ONCOGENE
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model
- (2016) Seth D. Goldstein et al. Oncotarget
- Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1
- (2015) D Weekes et al. ONCOGENE
- Wnt/ß-catenin signalling and the dynamics of fate decisions in early mouse embryos and embryonic stem (ES) cells
- (2015) Silvia Muñoz-Descalzo et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells
- (2015) Changbao Chen et al. Oncotarget
- Focal Chromosomal Copy Number Aberrations Identify CMTM8 and GPR177 as New Candidate Driver Genes in Osteosarcoma
- (2015) Joeri Both et al. PLoS One
- Human lysyl oxidase-like 2
- (2014) Hee-Jung Moon et al. BIOORGANIC CHEMISTRY
- Lysine post-translational modifications of collagen
- (2014) Mitsuo Yamauchi et al. Essays in Biochemistry
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
- (2014) Xiang Chen et al. Cell Reports
- Wnt signalling in mouse gastrulation and anterior development: new players in the pathway and signal output
- (2013) Ruth M Arkell et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- c-Jun is required for the specification of joint cell fates
- (2013) A. Kan et al. GENES & DEVELOPMENT
- Expression of lysyl oxidase in human osteosarcoma and its clinical significance: A tumor suppressive role of LOX in human osteosarcoma cells
- (2013) XIN XU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- WNT signaling in bone homeostasis and disease: from human mutations to treatments
- (2013) Roland Baron et al. NATURE MEDICINE
- Wnt-mediated reciprocal regulation between cartilage and bone development during endochondral ossification
- (2012) Cheng Lu et al. BONE
- A uniform human Wnt expression library reveals a shared secretory pathway and unique signaling activities
- (2012) Rani Najdi et al. DIFFERENTIATION
- Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma
- (2012) Yang Liu et al. PLoS One
- Wntless functions in mature osteoblasts to regulate bone mass
- (2012) Z. Zhong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-Frequency Canonical Wnt Activation in Multiple Sarcoma Subtypes Drives Proliferation through a TCF/β-Catenin Target Gene, CDC25A
- (2011) Sapna Vijayakumar et al. CANCER CELL
- Single-vector inducible lentiviral RNAi system for oncology target validation
- (2011) Dmitri Wiederschain et al. CELL CYCLE
- Role of YAP/TAZ in mechanotransduction
- (2011) Sirio Dupont et al. NATURE
- Addition of pamidronate to chemotherapy for the treatment of osteosarcoma
- (2010) Paul A. Meyers et al. CANCER
- Generation of mice with a conditional null allele for Wntless
- (2010) April C. Carpenter et al. GENESIS
- Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor
- (2010) Hector M. Rodriguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stable murine chondrogenic cell lines derived from c-fos-induced cartilage tumors
- (2010) Zhao-Qi Wang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Wnt signal transduction pathways
- (2010) Yuko Komiya et al. Organogenesis
- Osteosarcoma incidence and survival rates from 1973 to 2004
- (2009) Lisa Mirabello et al. CANCER
- Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
- (2009) Maya Kansara et al. JOURNAL OF CLINICAL INVESTIGATION
- Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma
- (2009) Yongping Cai et al. JOURNAL OF PATHOLOGY
- Extra-Intestinal Manifestations of Familial Adenomatous Polyposis
- (2008) Emma J. Groen et al. ANNALS OF SURGICAL ONCOLOGY
- Lysyl Oxidase-Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas
- (2008) H. Peinado et al. CANCER RESEARCH
- Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease
- (2008) C. R. Walkley et al. GENES & DEVELOPMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started